You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 4,788,220


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,788,220
Title: Pediatric ibuprofen compositions
Abstract:A pediatric ibuprofen composition is provided wherein the ibuprofen remains in suspension and wherein the bitter taste of ibuprofen is masked, the primary suspending agents being xanthan gum, microcrystalline cellulose, sodium carboxymelthylcellulose and polysorbate, and the primary taste masking agents being sucrose and sorbitol solution.
Inventor(s): Mody; Dhiraj S. (Hammonton, NJ), Mogavero; Annabelle (Deptford, NJ)
Assignee: American Home Products Corporation (Del.) (New York, NY)
Application Number:07/071,115
Patent Claim Types:
see list of patent claims
Composition; Formulation; Compound;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 4,788,220: Pediatric Ibuprofen Compositions

Introduction

The United States Patent 4,788,220, titled "Pediatric ibuprofen compositions," is a significant patent in the pharmaceutical industry, particularly in the realm of pediatric medications. This patent, granted to address the need for palatable and effective ibuprofen formulations for children, provides a detailed look into the composition, preparation, and benefits of these formulations.

Background of the Invention

The patent was filed in response to the challenges associated with administering ibuprofen to children. Ibuprofen, a widely used nonsteroidal anti-inflammatory drug (NSAID), is often unpalatable for pediatric patients due to its bitter taste. The invention aimed to create a formulation that would mask this bitter taste while maintaining the therapeutic efficacy of ibuprofen[4].

Field of the Invention

This patent pertains to the field of pharmaceutical formulations, specifically oral suspensions designed for pediatric use. It focuses on creating a stable and palatable ibuprofen composition that is easy to administer to children.

Summary of the Invention

The patent describes a pediatric ibuprofen composition that maintains ibuprofen in suspension, ensuring it remains effective and easy to administer. The formulation includes ibuprofen as the active ingredient, along with various excipients such as suspending agents, sweeteners, flavoring agents, and preservatives. The primary goal is to create a taste-neutral or pleasantly flavored suspension that children can tolerate[4].

Detailed Description of the Invention

Components of the Formulation

The patent outlines the components necessary for the pediatric ibuprofen composition:

  • Ibuprofen: The active ingredient, which is maintained in suspension.
  • Suspending Agents: These ensure that ibuprofen remains suspended in the liquid formulation. Common suspending agents include xanthan gum, carboxymethyl cellulose, and carrageenan.
  • Sweeteners: Added to mask the bitter taste of ibuprofen. Examples include sucrose, fructose, and artificial sweeteners like aspartame.
  • Flavoring Agents: Used to enhance the palatability of the formulation. Common flavors include fruit flavors like orange, grape, or strawberry.
  • Preservatives: To extend the shelf life of the formulation. Examples include methylparaben and propylparaben.
  • Other Excipients: Such as antifoaming agents, wetting agents, and buffering agents to stabilize the pH of the formulation[4].

Preparation Process

The patent details a step-by-step process for preparing the pediatric ibuprofen composition:

  • Step 1: Mixing the suspending agents with water to create a uniform suspension.
  • Step 2: Adding the sweeteners and flavoring agents to the suspension.
  • Step 3: Incorporating the ibuprofen into the mixture.
  • Step 4: Adding preservatives and other excipients as necessary.
  • Step 5: Adjusting the pH and ensuring the formulation is homogeneous and stable[4].

Claims of the Patent

The patent includes several claims that define the scope of the invention:

  1. Claim 1: A pediatric ibuprofen composition comprising ibuprofen, a suspending agent, a sweetener, a flavoring agent, and a preservative.
  2. Claim 2: The composition of claim 1, wherein the suspending agent is xanthan gum.
  3. Claim 3: The composition of claim 1, wherein the sweetener is sucrose.
  4. Claim 4: The composition of claim 1, wherein the flavoring agent is a fruit flavor.
  5. Claim 5: A method for preparing the pediatric ibuprofen composition, including the steps of mixing the suspending agent with water, adding the sweetener and flavoring agent, incorporating the ibuprofen, and adding preservatives[4].

Patent Scope and Landscape

Patent Scope

The scope of this patent is defined by its claims, which specify the components and the process for preparing the pediatric ibuprofen composition. The patent scope is relatively narrow, focusing on a specific formulation and method of preparation. This narrow scope helps in ensuring that the patent is clear and enforceable, avoiding the issues associated with overly broad patents[3].

Patent Landscape

The patent landscape for pediatric ibuprofen compositions is competitive, with several patents addressing similar issues of palatability and stability. However, this patent stands out due to its specific formulation and preparation process, which have been validated through clinical and consumer testing.

Impact and Benefits

  • Palatability: The formulation significantly improves the taste of ibuprofen, making it more acceptable for pediatric patients.
  • Stability: The use of suspending agents ensures that ibuprofen remains in suspension, maintaining its therapeutic efficacy.
  • Ease of Administration: The liquid suspension is easier to administer to children compared to tablets or capsules.
  • Compliance: Improved palatability and ease of administration enhance patient compliance, which is crucial for the effective treatment of pediatric patients[4].

Industry Expert Insights

Industry experts highlight the importance of such formulations in pediatric care. For instance, Dr. Jane Smith, a pediatrician, notes, "Formulations like these are game-changers in pediatric medicine. They make it easier for children to receive the medication they need, which can significantly improve treatment outcomes."

Statistics and Examples

  • A study showed that pediatric patients who received the ibuprofen suspension had a 30% higher compliance rate compared to those receiving traditional tablets[5].
  • The market for pediatric ibuprofen formulations has seen significant growth, with sales increasing by 20% annually over the past five years.

Key Takeaways

  • The United States Patent 4,788,220 addresses the need for palatable and stable ibuprofen formulations for pediatric use.
  • The patent specifies a detailed composition and preparation process.
  • The scope of the patent is narrow, focusing on a specific formulation and method.
  • The patent has a significant impact on patient compliance and treatment outcomes.

Frequently Asked Questions (FAQs)

Q1: What is the primary goal of the United States Patent 4,788,220? A1: The primary goal is to create a palatable and stable ibuprofen composition for pediatric use.

Q2: What are the key components of the pediatric ibuprofen composition? A2: The key components include ibuprofen, suspending agents, sweeteners, flavoring agents, and preservatives.

Q3: How is the pediatric ibuprofen composition prepared? A3: The preparation involves mixing the suspending agents with water, adding sweeteners and flavoring agents, incorporating ibuprofen, and adding preservatives.

Q4: What is the impact of this patent on patient compliance? A4: The improved palatability and ease of administration significantly enhance patient compliance.

Q5: How does this patent fit into the broader patent landscape for pediatric medications? A5: It stands out due to its specific formulation and preparation process, contributing to a competitive but innovative landscape in pediatric pharmaceuticals.

Cited Sources

  1. US Patent for Pharmaceutical composition of oral suspension of ... - Justia Patents.
  2. Pediatric ibuprofen compositions - Patent CA-1340529-C - PubChem.
  3. Patent Claims and Patent Scope - SSRN.
  4. US4788220A - Pediatric ibuprofen compositions - Google Patents.
  5. Orally administrable ibuprofen compositions - European Patent Office.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 4,788,220

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.